Silliker Implements Ridascreen Gliadin to Test Food for Gluten
Silliker, a Merieux NutriSciences Company, last week announced it has expanded its repertoire of food allergen testing services by implementing the RIDASCREEN® R5 Gliadin test kit for gluten analysis in food. Now in use at Silliker's laboratories in Crete, IL, and Markham, ON (Canada), the RIDASCREEN Gliadin test is a tool to help food manufacturers verify that their products meet the definition of "gluten-free" in the labeling rule issued by the U.S. Food and Drug Administration in August 2013.
Developed by R-Biopharm, RIDASCREEN Gliadin is a quantitative sandwich enzyme immunoassay that tests for the presence of gluten, utilizing the R5 monoclonal antibody as recommended by Codex Alimentarius. Approved by AOAC as Official First Action Method (2012.01), AOAC Research Institute (AOAC-RI 120601) and AACCI as method 38.50.01, RIDASCREEN Gliadin is widely accredited for the quantitation of gluten prolamins in food. FDA has issued notice that it will employ this technology as part of its regulatory enforcement activities, according to Silliker.